scholarly journals Knowing Your Pharmacist's Name

2015 ◽  
Vol 6 (3) ◽  
Author(s):  
Lisa Dragic ◽  
Vivan Pham ◽  
Albert Wertheimer
Keyword(s):  
Health Care ◽  
Pilot Study ◽  
Health Care Providers ◽  
General Public ◽  
Care Providers ◽  
Female Patients ◽  
Effective Use

Pharmacists are the most accessible health care providers to the general public. Pharmacists are experts in helping patients get the most out of today’s complicated medications. Pharmacists ensure safe and effective use of medications. The American Pharmacists Association pitched a campaign, “Know your medicine, know your pharmacist.” Before one can know their medicine, one must know their pharmacist. This study was conducted to see whether older or younger and male verse female patients knew their pharmacist’s name better in the Philadelphia area, as a pilot study.   Type: Commentary

scholarly journals Improving Access to Cancer Treatments: The Role of Biosimilars

2017 ◽  
Vol 3 (5) ◽  
pp. 596-610 ◽  
Author(s):  
Rakesh Chopra ◽  
Gilberto Lopes
Keyword(s):  
Health Care ◽  
Cancer Treatment ◽  
Health Care Providers ◽  
Cost Effective ◽  
Cancer Therapies ◽  
Care Providers ◽  
Cancer Treatments ◽  
Reference Drug ◽  
Effective Use ◽  
The Cost

Biologics play a key role in cancer treatment and are principal components of many therapeutic regimens. However, they require complex manufacturing processes, resulting in high cost and occasional shortages in supply. The cost of biologics limits accessibility of cancer treatment for many patients. Effective and affordable cancer therapies are needed globally, more so in developing countries, where health care resources can be limited. Biosimilars, which have biologic activity comparable to their corresponding reference drugs and are often more cost effective, have the potential to enhance treatment accessibility for patients and provide alternatives for decision makers (ie, prescribers, regulators, payers, policymakers, and drug developers). Impending patent expirations of several oncology biologics have opened up a vista for the development of corresponding biosimilars. Several countries have implemented abbreviated pathways for approval of biosimilars; however, challenges to their effective use persist. Some of these include designing appropriate clinical trials for assessing biosimilarity, extrapolation of indications, immunogenicity, interchangeability with the reference drug, lack of awareness and possibly acceptance among health care providers, and potential political barriers. In this review, we discuss the potential role and impact of biosimilars in oncology and the challenges related to their adoption and use. We also review the safety and efficacy of some of the widely used biosimilars in oncology and other therapeutic areas (eg, bevacizumab, darbepoetin, filgrastim, rituximab, and trastuzumab).

scholarly journals Teaching Health Care Providers To Provide Spiritual Care: A Pilot Study

2015 ◽  
Vol 18 (5) ◽  
pp. 408-414 ◽  
Author(s):  
Angelika A. Zollfrank ◽  
Kelly M. Trevino ◽  
Wendy Cadge ◽  
Michael J. Balboni ◽  
Mary Martha Thiel ◽  
...  
Keyword(s):  
Health Care ◽  
Pilot Study ◽  
Health Care Providers ◽  
Spiritual Care ◽  
Care Providers

scholarly journals Novel Representation of Clinical Information in the ICU

2010 ◽  
Vol 01 (02) ◽  
pp. 116-131 ◽  
Author(s):  
V. Herasevich ◽  
A. Ahmed ◽  
O. Gajic ◽  
B.W. Pickering
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
User Interfaces ◽  
Information Overload ◽  
Care Delivery ◽  
Tertiary Care ◽  
Clinical Information ◽  
Care Providers ◽  
Effective Use ◽  
Physician Order Entry

SummaryThe introduction of electronic medical records (EMR) and computerized physician order entry (CPOE) into the intensive care unit (ICU) is transforming the way health care providers currently work. The challenge facing developers of EMR’s is to create products which add value to systems of health care delivery. As EMR’s become more prevalent, the potential impact they have on the quality and safety, both negative and positive, will be amplified. In this paper we outline the key barriers to effective use of EMR and describe the methodology, using a worked example of the output. AWARE (Ambient Warning and Response Evaluation), is a physician led, electronic-environment enhancement program in an academic, tertiary care institution’s ICU. The development process is focused on reducing information overload, improving efficiency and eliminating medical error in the ICU. Citation: Pickering BW, Herasevich V, Ahmed A, Gajic O. Novel representation of clinical information in the ICU – developing user interfaces which reduce information overload. Appl Clin Inf 2010; 1: 116–131 http://dx.doi.org/10.4338/ACI-2009-12-CR-0027

scholarly journals Developing an Indonesian fertility preservation questionnaire for health care providers treating patients with cancer: A preliminary pilot study

F1000Research ◽  
2019 ◽  
Vol 7 ◽  
pp. 1890
Author(s):  
Achmad Kemal Harzif ◽  
Raymond Surya ◽  
Mila Maidarti ◽  
Ana Mariana ◽  
Bara Tracy Lovita ◽  
...  
Keyword(s):  
Health Care ◽  
Pilot Study ◽  
Fertility Preservation ◽  
Health Care Providers ◽  
Expert Panel ◽  
World Health ◽  
Cognitive Interviewing ◽  
Care Providers ◽  
Patients With Cancer ◽  
Forward Translation

Background: Early detection and advanced treatment increases the five-year survival rate of patients with cancer. However, long-term cancer therapy, such as chemotherapy and radiotherapy, can have negative effects, such as infertility. This study aimed to develop a standardized Indonesian questionnaire, which would be used to assess the quality of health care providers’ knowledge, attitude, and practice regarding fertility preservation in patients with cancer. Methods: A pilot study was performed in January and February 2018 at Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. An existing questionnaire was translated from English to Indonesian using forward translation, back translation, expert panel, pretesting, and cognitive interviewing. Ten subspecialists in the following departments made up an expert panel, who were involved in pretesting and cognitive interviewing: pediatric hematology-oncology, hematology-oncology/internal medicine, gynecologic oncology, gynecologic immune-endocrinology, radiology-oncology, and surgical oncology. Results: The questionnaire was successfully translated. The ten respondents stated that the maximum age for women’s fertility preservation is 40 years of age (60%), 45 years of age (30%), or had no maximum age (10%). Additionally, the respondents stated that the maximum age for men’s fertility preservation is 40 years of age (30%), 50 years of age (20%), or had no maximum age (50%). The respondents’ knowledge stated that > 50% of them were aware but do not know enough about fertility preservation. The respondents stated that more than 50% of them give feedback agreeing to fertility preservation, and they always give advice about fertility preservation to their patients. Conclusion: The translation of the questionnaire followed translation steps from the World Health Organization and was adjusted based on the expert panel’s comments concerning fertility preservation. This validated questionnaire tool in Indonesian can be used for research purposes and clinical evaluation of fertility preservation among health care providers in Indonesia.

Sign in / Sign up

Export Citation Format

Share Document